Matches in Nanopublications for { ?s ?p "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP623202.RAXZiXm7zoWZriO0XM8M5MrbsZPGFKEXn9TAD50ptpWzk130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623202.RAXZiXm7zoWZriO0XM8M5MrbsZPGFKEXn9TAD50ptpWzk130_provenance.
- assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP687804.RACGOVoq_iQXkCzmcJb3qFTBguhPw1DP6-7s7XH0MKlZU130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687804.RACGOVoq_iQXkCzmcJb3qFTBguhPw1DP6-7s7XH0MKlZU130_provenance.
- NP625662.RABwIgT9_OGoTiZgLECjmnIDifMNiYrgYjl9VTE6OJwKw130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625662.RABwIgT9_OGoTiZgLECjmnIDifMNiYrgYjl9VTE6OJwKw130_provenance.
- NP687807.RATFoQufo75ULQTHaetmX2aV3lgzsv9vI9iK7zAJrrlOU130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687807.RATFoQufo75ULQTHaetmX2aV3lgzsv9vI9iK7zAJrrlOU130_provenance.
- NP412332.RAotIiv9FsVfVT4a-kxDHqjBqHT9j7rKf6LQ9plc-8M0E130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412332.RAotIiv9FsVfVT4a-kxDHqjBqHT9j7rKf6LQ9plc-8M0E130_provenance.
- NP687802.RAlYn6OTqx899x1RPYCbLsRwJ53-r2Y8CBTt6LytwEl2E130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687802.RAlYn6OTqx899x1RPYCbLsRwJ53-r2Y8CBTt6LytwEl2E130_provenance.
- NP624519.RAPmYvfFHMvEq4u5n4yj1Qf6lljO4aYYQ5F4R7cbdlcxo130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624519.RAPmYvfFHMvEq4u5n4yj1Qf6lljO4aYYQ5F4R7cbdlcxo130_provenance.
- NP622063.RA6N6IoYug7euzK7VPhibn_8AnyF1KIpLLuWZBwKi1VwI130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622063.RA6N6IoYug7euzK7VPhibn_8AnyF1KIpLLuWZBwKi1VwI130_provenance.
- NP687810.RALPCtszRaj1_4XaOf44xoyCTajGgj4EH0WMiPOwMn4xM130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687810.RALPCtszRaj1_4XaOf44xoyCTajGgj4EH0WMiPOwMn4xM130_provenance.
- NP687812.RAMtoUi27t8_NZhuDMD-BT0po1U9qoqPfXsH49Q_5Zlb4130_assertion description "[Our findings provide mechanistic insights into PI3K dependency in oncogenic networks and provide a rationale for targeting class IA PI3K, alone or together with mTOR, in the treatment of Ph+ ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP687812.RAMtoUi27t8_NZhuDMD-BT0po1U9qoqPfXsH49Q_5Zlb4130_provenance.